Utility and prognostic value of 18F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma

Mohammed A. Aljama, M. Hasib Sidiqi, Francis K. Buadi, Martha Q. Lacy, Morie A. Gertz, Angela Dispenzieri, David Dingli, Eli Muchtar, Amie L. Fonder, Suzanne R. Hayman, Miriam A. Hobbs, Wilson I. Gonsalves, Rahma M. Warsame, Taxiarchis Kourelis, Yi Lisa Hwa, Prashant Kapoor, Robert A. Kyle, Nelson Leung, Ronald S Go, S. Vincent RajkumarShaji K. Kumar

Research output: Contribution to journalArticlepeer-review

13 Scopus citations


Positron emission tomography-computed tomography (PET-CT) can identify bony lesions, assess disease burden, and detect extramedullary disease (EMD) in patients with multiple myeloma. We retrospectively reviewed records of patients who underwent PET-CT within 60 days of a new diagnosis (before therapy commenced) to identify the nature and prognostic impact of PET-CT abnormalities. Patients (N = 313) were seen from April 2005 through June 2017. Of the 234 patients (75%) with focal lesions (FLs), 182 (58%) had at least 3 FLs, 38 (12%) had EMD, and 204 (65%) had documented myelomatous lytic lesions. The median maximum standardized uptake value (SUVmax) for the entire cohort was 5.9 (range 1.5-48.3). Presence of at least 3 FLs and EMD predicted inferior overall survival (OS); median OS was 57.8 months for patients with 3 or more FLs and 103.6 months for patients with fewer than 3 FLs (P =.003). The median OS was 45.5 and 71.8 months for patients with and without EMD, respectively (P =.004). No clear SUVmax cutoff was predictive of progression-free survival or OS. PET-CT is a valuable tool for assessing disease burden and could provide prognostic information about a contemporary cohort of patients with newly diagnosed myeloma who received treatment with novel agents.

Original languageEnglish (US)
JournalAmerican Journal of Hematology
StateAccepted/In press - Jan 1 2018


  • advanced imaging
  • myeloma
  • prognosis

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Utility and prognostic value of <sup>18</sup>F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma'. Together they form a unique fingerprint.

Cite this